

1,402,507 filings since 2004 · latest accepted Nov 4, 2026, 5:30 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jul 30, 2026 accepted 5:07 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Nov 18, 2024 accepted 7:01 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreementOther events |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Oct 2, 2024 accepted 4:10 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Aug 1, 2024 accepted 4:11 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Nov 1, 2023 accepted 7:09 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Dec 27, 2022 accepted 7:00 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation8.01Other events | DocumentSEC ↗ |
Apr 29, 2021 accepted 4:25 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Apr 21, 2021 accepted 4:43 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Jan 14, 2021 accepted 7:53 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 26, 2019 accepted 7:53 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Jan 29, 2019 accepted 8:16 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Dec 28, 2018 accepted 4:08 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Sep 28, 2018 accepted 4:50 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Dec 1, 2017 accepted 4:33 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Sep 19, 2017 accepted 5:09 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Sep 12, 2017 accepted 7:08 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Jun 2, 2017 accepted 4:05 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Feb 14, 2017 accepted 5:05 PM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
May 27, 2016 accepted 6:14 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 9, 2016 accepted 8:00 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 22, 2015 accepted 8:51 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Jan 20, 2015 accepted 8:40 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Jan 15, 2015 accepted 8:42 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Jan 13, 2015 accepted 9:08 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Nov 12, 2014 accepted 8:01 AM ET | ALDXAldeyra Therapeutics, Inc. | 1.01Material agreement2.02Earnings release2.03New debt obligation | DocumentSEC ↗ |